miR-92b-3p Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting MAP3K2 in a Mouse Model

Abstract

Objective

MicroRNAs are well-known RNA regulators modulating biological functions in complex signaling networks. This work aims to explore the impact of microRNA-92b-3p (miR-92b-3p) on myocardial ischemia-reperfusion (I/R) injury.

Materials and Methods

The I/R model was established by left anterior descending coronary artery ligation in mice. The hemodynamic parameters were detected through a multichannel physiological recorder. Myocardial injury markers: serum cardiac troponin I, myocardial kinase isoenzyme (creatine kinase-MB), and serum inflammatory factors (tumor necrosis factor-α, interleukin [IL]-1β, and IL-6) were evaluated by enzyme-linked immunosorbent assay. Cardiac tissue oxidative stress-related factors (malondialdehyde, glutathione peroxidase, total antioxidation capability, and superoxide dismutase) were assessed by colorimetry, myocardial pathology was observed by hematoxylin–eosin staining, and cardiomyocyte apoptosis was measured by triphosphate nick end-labeling staining, as well as the expression of miR-92b-3p and mitogen-activated protein kinase kinase kinase 2 (MAP3K2) in cardiac tissues were determined by reverse transcription quantitative polymerase chain reaction or western blot assay. The targeting relationship between miR-92b-3p and MAP3K2 was verified by bioinformatics, RNA immunoprecipitation, and luciferase reporter assays.

Results

miR-92b-3p was lowly expressed and MAP3K2 was highly expressed in myocardial I/R injury mice. Upregulation of miR-92b-3p improved hemodynamic indices, decreased serum levels of myocardial injury biomarkers, inhibited serum inflammatory response, alleviated cardiac tissue oxidative stress, relieved myocardial pathology, and reduced cardiomyocyte apoptosis during the myocardial I/R injury in mice. MAP3K2 was a direct target gene of miR-92b-3p.

Conclusion

This research suggests that miR-92b-3p protects against myocardial I/R injury by inhibiting MAP3K2, which may provide novel candidates for treatment of myocardial I/R injury.

Keywords

microRNA-92b-3p - mitogen-activated protein kinase kinase kinase 2 - myocardial ischemia-reperfusion injury - myocardial infarction - apoptosis

Publication History

Received: 03 August 2023

Accepted: 25 March 2024

Article published online:
01 May 2024

• References

• 1 Sugiyama A, Mitsui A, Okada M, Yamawaki H. Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats. J Vet Med Sci 2019; 81 (04) 522-531
• 2 Chen G, Yang L, Zhong L. et al. Delivery of hydrogen sulfide by ultrasound targeted microbubble destruction attenuates myocardial ischemia-reperfusion injury. Sci Rep 2016; 6: 30643
• 3 Wang N, Song G, Yang Y, Yuan W, Qi M. Inactivated Lactobacillus promotes protection against myocardial ischemia-reperfusion injury through NF-κB pathway. Biosci Rep 2017; 37 (06) BSR20171025
• 4 Lee FY, Shao PL, Wallace CG. et al. Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats. Int J Mol Sci 2018; 19 (09) 2782
• 5 Marinescu MC, Lazar AL, Marta MM, Cozma A, Catana CS. Non-coding RNAs: prevention, diagnosis, and treatment in myocardial ischemia-reperfusion injury. Int J Mol Sci 2022; 23 (05) 2728
• 6 Liu L, Wang D, Qiu Y, Dong H, Zhan X. Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-κB signalling pathway and inducing apoptosis. Exp Ther Med 2018; 15 (03) 2655-2660
• 7 Kunecki M, Płazak W, Podolec P, Gołba KS. Effects of endogenous cardioprotective mechanisms on ischemia-reperfusion injury. Postepy Hig Med Dosw 2017; 71 (00) 20-31
• 8 Li Y, Li Z, Liu J, Liu Y, Miao G. miR-190-5p alleviates myocardial ischemia-reperfusion injury by targeting PHLPP1. Dis Markers 2021; 2021: 8709298
• 9 Zhou M, Cai J, Tang Y, Zhao Q. MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury. Med Hypotheses 2013; 81 (01) 108-110
• 10 Xu L, Cao H, Xie Y. et al. Exosome-shuttled miR-92b-3p from ischemic preconditioned astrocytes protects neurons against oxygen and glucose deprivation. Brain Res 2019; 1717: 66-73
• 11 Yu XJ, Huang YQ, Shan ZX. et al. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2. Life Sci 2019; 232: 116635
• 12 Lee J, Heo J, Kang H. miR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia. Cell Death Differ 2019; 26 (09) 1782-1795
• 13 Ben-Zvi I, Volinsky N, Grosman-Rimon L. et al. Cardiac-peripheral transvenous gradients of microRNA expression in systolic heart failure patients. ESC Heart Fail 2020; 7 (03) 835-843
• 14 Fu DL, Jiang H, Li CY, Gao T, Liu MR, Li HW. MicroRNA-338 in MSCs-derived exosomes inhibits cardiomyocyte apoptosis in myocardial infarction. Eur Rev Med Pharmacol Sci 2020; 24 (19) 10107-10117
• 15 Wang AD, Dai LF, Yang L. et al. Upregulation of miR-335 reduces myocardial injury following myocardial infarction via targeting MAP3K2. Eur Rev Med Pharmacol Sci 2021; 25 (01) 344-352
• 16 Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123 (01) 92-100
• 17 Liu B, Wu X, Liu B. et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 2012; 1822 (11) 1692-1704
• 18 Peterlin A, Počivavšek K, Petrovič D, Peterlin B. The role of microRNAs in heart failure: a systematic review. Front Cardiovasc Med 2020; 7: 161
• 19 Ji R, Cheng Y, Yue J. et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100 (11) 1579-1588
• 20 Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012; 14 (02) 147-154
• 21 Taurino C, Miller WH, McBride MW. et al. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 2010; 119 (08) 335-343
• 22 Borosch S, Dahmen E, Beckers C. et al. Characterization of extracellular vesicles derived from cardiac cells in an in vitro model of preconditioning. J Extracell Vesicles 2017; 6 (01) 1390391
• 23 Chen Z, Li Z, Jiang C, Jiang X, Zhang J. MiR-92b-3p promotes neurite growth and functional recovery via the PTEN/AKT pathway in acute spinal cord injury. J Cell Physiol 2019; 234 (12) 23043-23052
• 24 Yuan Q, Basit A, Liang W. et al. Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3. Sci Transl Med 2021; 13 (591) eabc2499
• 25 Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19 (06) 586-593
• 26 Xu W, Qian L, Yuan X, Lu Y. Regulation of a novel CircTRRAP/miR-761/MAP3K2 CeRNA cascade in inflammation, apoptosis, and oxidative stress in human AC16 cardiomyocytes under hypoxia conditions. Int Heart J 2023; 64 (03) 442-452
• 27 Liu E, Sun H, Wu J, Kuang Y. MiR-92b-3p regulates oxygen and glucose deprivation-reperfusion-mediated apoptosis and inflammation by targeting TRAF3 in PC12 cells. Exp Physiol 2020; 105 (10) 1792-1801